Provided by Tiger Trade Technology Pte. Ltd.

Norway Government Pension Fund

1,263.235
0.000
Number of Gainers:23
Number of Losers:15
Number of Flat:15
PE:- -
High:1,263.235
Open:1,263.235
Low:1,263.235
Close:1,263.235
Volume:- -
Turnover:- -
Market Cap:31.58T
Float Cap:20.39T

Loading ...

Sunac Services Files HKEX Next-Day Return Disclosing Share Buyback for Cancellation

Reuters
·
Sep 09

Automakers' August share of China's NEV market: BYD leads with 23.3%, Tesla returns to top 10

CnEVPost
·
Sep 09

Transcenta Licenses HiCB Bioprocessing Technology to WuXi Biologics for RMB 10 Million Upfront

Reuters
·
Sep 09

Transcenta Holding - to Receive RMB 10 Mln Upfront Payment and Milestone Payments

THOMSON REUTERS
·
Sep 09

Transcenta Holding - Grants WuXi Biologics Non-Exclusive License to Hicb Platform and Excelpro Cell Culture Media

THOMSON REUTERS
·
Sep 09

Gateway to Hong Kong: Strategic Meeting Bridges Mainland Enterprises with Global Capital Markets

Deep News
·
Sep 09

Market Chatter: Wharf REIC Reportedly Seals Deal to Sell Last Singapore Property

MT Newswires Live
·
Sep 09

Bilibili Completes Us$500 Million Convertible Senior Notes Offering Due 2031

Reuters
·
Sep 09

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Sep 09

Xiaomi-W Allocates HK$50.08 Million to Share Buyback on September 9

Stock News
·
Sep 09

Xiaomi Bought Back 1.9 Mln Class B Shares for HKD50 Mln on Sept 9 - HKEX

THOMSON REUTERS
·
Sep 09

Xiaomi Files HKEX Next-Day Disclosure Return Reporting Share Buyback for Cancellation

Reuters
·
Sep 09

Link REIT Allocates Approximately HK$31.05 Million to Buy Back 800,000 Units on September 9

Stock News
·
Sep 09

Tencent Bought Back 231,000 Shares on Sept 9, HKEX Filing Shows

Reuters
·
Sep 09

Link REIT Files HKEX Next-Day Disclosure Return After Unit Buyback

Reuters
·
Sep 09

Smithfield Falls on Weaker Q3 Outlook

Reuters
·
Sep 09

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Sep 09

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Sep 09

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

Stock News
·
Sep 09

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

Reuters
·
Sep 09